Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Trading Statement

6 Oct 2009 07:00

RNS Number : 2761A
Byotrol PLC
06 October 2009
 



Byotrol plc (the "Company")

UPDATE ON TRADING

The Board is pleased to announce a further positive update on trading in relation to the six months ended 30 September 2009.

As highlighted in the announcement dated 17 September, the first half of the current financial year has been characterised by a significant increase in orders for Byotrol products. This trend has continued through to the end of the half year and as a result the Board is pleased to report that product sales for the six months ended 30 September 2009 will be in the order of £1.5m (£0.2m for the comparative period). There was an additional one off license payment of £450k bringing total revenues to approximately £1.9m as compared to £0.4m for the same period last year.

The Board believes certain key factors have underpinned the interest in, and orders for, Byotrol products. One has been the increased public and businesss awareness of the products following the success of the Manchester Royal Infirmary trial which demonstrated that Byotrol outperformed the NHS's gold standard cleaning regime. Another is the increased public awareness of the requirement for better personal hygiene stemming, in part, from the threat of swine flu. The third key factor is the continued growth in the recognition of Byotrol's superiority to other products in that it continues to work even when dry.

Highlights of the Company's activities during the period include the receipt of significant orders for supply to major retailers for the protection of their staff. The Company has also despatched material orders to Arco, one of the UK's leading Health and Safety product suppliers. 

"I am very pleased with the sales performance for the first half" said CEO David McRobbie. "The unprecedented increase in orders gave rise to some temporary issues in relation to sourcing bottles and caps and the Company turned to suppliers in both Europe and North America. This has had an unavoidable short term impact on margins. We have, however, addressed the bottles supply issue via a manufacturing arrangement with a major bottle supplier. Accordingly, the Board expect that margins should improve in the second half of the current financial year."

The eight fold increase in activity levels has also been reflected in an increased working capital requirement and the Board has taken steps to address this. As at 30 September, the Company had cash of £1.6m.

The Company has a good forward order book for the third quarter of the financial year but the nature of the business means that, at the current time, there is more limited visibility for the final quarter. As a consequence, the Board's current view is that the results for the financial year will be in line with market expectations.

The Board will provide a further update at the time of the announcement of the interim results in mid November.

Enquiries:

 

Byotrol plc
 
 
Richard Bell, Finance Director
 
Tel 0161 277 9518
Charles Stanley Securities
Nominated Adviser & Broker
 
 
Philip Davies / Carl Holmes
Tel 020 7149 6000

 

6 October 2009 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUGAGUUPBPUA
Date   Source Headline
5th Sep 20077:01 amRNSDirector/PDMR Shareholding
4th Sep 20077:00 amRNSDirectorate Change
31st Aug 200710:07 amRNSTotal Voting Rights
16th Aug 20078:41 amRNSAIM RULE 26 INFORMATION
6th Aug 20072:49 pmRNSAdditional Listing
1st Aug 20078:21 amRNSTotal Voting Rights
1st Aug 20077:01 amRNSDirector/PDMR Shareholding
30th Jul 20071:04 pmRNSAGM Statement
30th Jul 20077:01 amRNSJoint Venture
20th Jun 20077:01 amRNSAnnual Report and Accounts
8th Jun 20077:00 amRNSAdditional Listing
4th Jun 20077:00 amRNSNEW GLOBAL CONTRACT
4th May 20077:01 amBUSBYOTROL plc • HEALTHCARE PRODUCT LAUNCH
18th Apr 20077:45 amRNSTrading Statement
30th Mar 20079:24 amRNSTotal Voting Rights
22nd Mar 20072:47 pmRNSHolding(s) in Company
19th Mar 20079:56 amRNSHolding(s) in Company
19th Mar 20079:52 amRNSHolding(s) in Company
19th Mar 20079:51 amRNSHolding(s) in Company
19th Mar 20079:49 amRNSHolding(s) in Company
13th Mar 20073:28 pmRNSAdditional Listing
28th Feb 20071:04 pmRNSTotal Voting Rights
23rd Feb 20077:01 amRNSAdditional Listing
21st Feb 20077:01 amRNSDirector/PDMR Shareholding
8th Feb 20073:54 pmRNSAdditional Listing
5th Feb 20072:52 pmRNSHolding(s) in Company
19th Jan 20072:30 pmRNSTotal Voting Rights
12th Jan 20073:07 pmRNSIssue of Equity
14th Dec 20065:00 pmRNSTotal Voting Rights
11th Dec 20067:00 amRNSInterim Results
27th Nov 20069:32 amRNSBoard Appointment
14th Nov 20067:03 amRNSSynergy Healthcare Agreement
1st Nov 20067:01 amRNSIssue of Equity
26th Oct 20061:12 pmBUSByotrol Plc Distribution Agreements Signed for Healthcare Sector
26th Oct 20061:02 pmBUSByotrol Plc Distribution Agreements Signed for Healthcare Sector
26th Oct 200612:28 pmBUSByotrol Plc Distribution Agreements Signed for Healthcare Sector
26th Oct 200610:24 amRNSDistribution Agreements
16th Oct 20067:01 amBUSByotrol Plc: Result of Byotrol Use in Hospital
18th Sep 200610:56 amBUSREPEAT: Byotrol Plc: Chinese Patent Granted and Customer Orders Shipped
18th Sep 200610:30 amBUSByotrol Plc: Chinese Patent Granted and Customer Orders Shipped
11th Sep 20067:01 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.